Clinical Trials Directory

Trials / Sponsors / Catherine Bollard

Catherine Bollard

Academic / Other · 14 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
CompletedHIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
HIV Associated Lymphoma
Phase 22021-10-25
Active Not RecruitingMesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)
Congenital Heart Disease (CHD)
Phase 12020-07-29
Active Not RecruitingEvaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in
HIV-Infected Individuals
Phase 12020-05-01
Active Not RecruitingTumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Phase 12019-06-24
CompletedHIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals
HIV Infections
Phase 12019-03-21
Active Not RecruitingMulti-antigen T Cell Infusion Against Neuro-oncologic Disease
Brain Tumor
Phase 12018-12-12
CompletedSafety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Phase 12018-06-07
RecruitingAdoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
Viral Infection
Phase 1 / Phase 22018-01-24
CompletedHaploidentical Hematopoietic Stem Cell Transplantation
Sickle Cell-thalassemia Disease, Thalassemia
Phase 12015-01-01
RecruitingMulti-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the T
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Phase 12015-01-01
CompletedAllogeneic Virus-specific T Cell Lines (VSTs)
Viral Infections After HSCT
Phase 12014-10-28
CompletedMultivirus-specific Cytotoxic T Lymphocytes (mCTL)
Refractory Viral Infections
Phase 12014-04-01
CompletedAllogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
EBV, CMV, Adenovirus
Phase 12014-02-01
CompletedCytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma
Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma
Phase 12013-11-01